Daniel Lang

Insider Reports History

Location
Buffalo, NY
Signature
/s/Steven Adams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Lang:

Company Role Class Num Shares Value Price $ Report Date Ownership
Athenex, Inc. Pres Cell Therapy, VP Corp Dev Common Stock 81,590 $110,962 $1.36 16 Sep 2022 Direct
Athenex, Inc. Pres Cell Therapy, VP Corp Dev Stock Option (Right to Buy) 200,000 16 Sep 2022 Direct
Athenex, Inc. Pres Cell Therapy, VP Corp Dev Restricted Stock Units 37,500 16 Sep 2022 Direct

Insider Reports Filed by Daniel Lang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122050508-lang-daniel-2022-09-16 Athenex, Inc. 16 Sep 2022 3 -$1,766 4 Pres Cell Therapy, VP Corp Dev 19 Sep 2022, 16:19
/report/000120919122042900-lang-daniel-2022-07-20 Athenex, Inc. 20 Jul 2022 1 $0 4 Pres Cell Therapy, VP Corp Dev 21 Jul 2022, 17:28
/report/000120919121067301-lang-daniel-2021-11-22 Athenex, Inc. 22 Nov 2021 0 $0 3 Pres Cell Therapy, VP Corp Dev 01 Dec 2021, 16:07